From continually evolving science to outdated business models, precision medicine faces hurdles that challenge its promise. PharmaVoice interviews industry leaders, including Precision for Medicine President Chad Clark, on the issues they encounter—and the solutions they foresee.   Read the article

What does the future hold for the manufacturing and clinical landscape? Pharma iQ asked Precision leaders Scott Marshall, PhD and Jeremy Schafer, PharmD, MBA. From gene therapy cures for chronic diseases to continuing price pressure on manufacturers, the role of machine learning to the role of companion diagnostics, their insights […]

ADDITION OF NATIVE ARTIFICIAL INTELLIGENCE CAPABILITY PROVIDES CLIENTS WITH INTUITIVE, INTERPRETABLE, AND INTERACTIVE BIOMARKER-BASED MODELS Bethesda, MD – March 6, 2019 – Precision for Medicine, part of Precision Medicine Group, today announced the acquisition of SimplicityBio, adding artificial intelligence to Precision’s QuartzBio™ multiomic data integration and informatics platform. The addition of […]